THURSDAY MARCH 15, 2018 - Speakers and Titles are Subject to Change
Session   Speaker Company Time
Registration   7:00-8:00
Conference Opening   Bikash Verma, Celyad  8:00-8:05

Session I: The Current Landscape

Chair:  David Sykes, Mass General/Harvard

Talk Title Speaker Company Time
Session Introduction  David Sykes  Mass General/Harvard 8:05-8:10
State of the Clinic: Treating AML in 2018  Andrew M. Brunner Massachusetts General Hospital 8:10-8:35
Genomics of Myeloid Malignancies  Coleman Lindsley  DFCI 8:35-9:00
AML after Transplant: Are We Becoming High Maintenance?  Yi-Bin Albert Chen  Mass General 9:00-9:25
Break     9:25-9:45
Panel Discussion      9:45-10:15

Session II: State of the Art Research and Treatment Updates

Chair: Daniel DeAngelo, DFCI

Talk Title Speaker Company Time
 Session Introduction  Daniel DeAngelo  DFCI 10:15-10:20
Immunotherapeutic Approaches for AML  Terry J. Fry Center for Cancer Research, National Cancer Institute 10:20-10:45
Novel CAR-T Therapy for AML  Bikash Verma  Celyad 10:45-11:10
Immune Checkpoint and Vaccine Approaches in AML Naval Daver   MD Anderson Cancer Center  11:10-11:35
Lunch and Networking     11:35-12:50
ADCs in AML: GO and Beyond  Patrick A. Zweidler-McKay ImmunoGen 12:50-1:15
Novel Targeting of AML and T-ALL  John F. DiPersio Washington University School of Medicine 1:15-1:40
Approaches to Differentiation Therapy in AML David Sykes Mass General/Harvard 1:40-2:05
Panel Discussion   2:05-2:35
Break     2:35-2:55

Plenary Lecture - Can AML Precision Science Become AML Precision Clinical Reality?


Gwen Nichols The Leukemia & Lymphoma Society 2:55-3:35

Session III: On the Horizon

Chair: Patrick Zweidler-McKay, ImmunoGen

Talk Title Speaker Company Time
 Session Introduction  Patrick Zweifler-McKay  ImmunoGen 3:35-3:40
FDA Work to Expedite the Development of Products to Address Serious and Life-Threatening Conditions Peter Marks CBER/US FDA 3:40-4:05
TriLeukeVax: A "Next Generation" Autologous Immunotherapy for Leukemia Karin Gaensler UCSF 4:05-4:30
Novartis Work on AML Scott Cameron NIBR 4:30-4:55
Closing Remarks Bikash Verma, Celyad 4:55-5:00
Evening Reception hosted by The Boston Society       5:00-6:15


Session I:  The Current Landscape

Session II:  State of the Art Research and Treatment Options

Session III:  On the Horizon


Click here to register for the AML 2018 conference online.

AML 2018 will take place

March 15, 2018

Broad Institute

Cambridge, MA


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy